OpenVSafe by OpenVAERS
Search V-safe

HJD-21285-19665

2 vaccinations 3 coded responses 11 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
853 / AZ
Registered
2021-01-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-20
    Registered in v-safe
  4. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to work
    Adult check-in
  5. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Insomnia — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Lack of appetite, insomnia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-18
    Survey response — day 28, dose 2
    MedDRA: Flushing, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Heart palpitations, flushing sensations
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-18
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-02-24
    Survey response — day 35, dose 2
    MedDRA: Neuralgia — Feeling: Good
    Free text: Nerve pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-26
  16. 2021-03-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-19Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-21

Systemic reaction (other): Lack of appetite, insomnia

Release 4 — day 28, dose 2

2021-02-18

Symptoms: Heart palpitations, flushing sensations

Release 4 — day 35, dose 2

2021-02-24

Symptoms: Nerve pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFlushing ✓ ✓ ✓
SDNeuralgia ✓ ✓ ✓
SDPalpitations ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release